Climb Bio CLYM
NASDAQ CLYM
$15.52 +0.93 (+6.37%)
As of: Sep 4, 2026 · 3:59 PM EDT

Climb Bio (CLYM) Other Working Capital Changes (2022 - 2026)

Climb Bio's (CLYM) quarterly Other Working Capital Changes came in at -$62000.0 in Q1 2026, down 5.08% YoY from -$65321.4 in Q1 2025, and up 70.05% on a QoQ basis from -$207000.0 in Q4 2025.

Analysis

Climb Bio (CLYM) Other Working Capital Changes (2022 - 2026) Analysis & Trends

Climb Bio (CLYM) has 5 years of Other Working Capital Changes data on file, last reported at -$62000.0 in Q1 2026.

  • Quarterly Other Working Capital Changes fell 5.08% year-over-year to -$62000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$210000.0 (up 19.85% YoY) and the FY2025 annual result came in at -$207000.0, up 36.7% from the prior year.
  • Other Working Capital Changes improved to -$62000.0 in Q1 2026, from -$207000.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $102000.0 in Q2 2024 to a low of -$269000.0 in Q3 2024.
  • A 5-year average of -$92937.5 and a median of -$104500.0 in 2023 frame the typical range for Other Working Capital Changes.
  • Annual changes were most pronounced in 2024 — Other Working Capital Changes surged 200.0% — and 2025, when it plunged 475.0%.
  • Tracing CLYM's Other Working Capital Changes over 5 years: stood at -$91000.0 in 2022, then slipped by 20.88% to -$110000.0 in 2023, then surged by 67.27% to -$36000.0 in 2024, then sank by 475.0% to -$207000.0 in 2025, then surged by 70.05% to -$62000.0 in 2026.
  • The last three Other Working Capital Changes figures came in at -$62000.0 (Q1 2026), -$207000.0 (Q4 2025), and $59000.0 (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Climb Bio 1.18 Bn 1.18 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 67,000.00
Jun 30, 2026 67,000.00
Mar 31, 2026 -62,000.00
Mar 31, 2026 -62,000.00
Dec 31, 2025 -39,000.00
Dec 31, 2025 -39,000.00
Sep 30, 2025 -59,000.00
Sep 30, 2025 -59,000.00
Jun 30, 2025 -50,000.00
Jun 30, 2025 -50,000.00
Mar 31, 2025 -59,000.00
Mar 31, 2025 -59,000.00
Dec 31, 2024 -36,000.00
Dec 31, 2024 -36,000.00
Sep 30, 2024 -42,000.00
Sep 30, 2024 -42,000.00
Jun 30, 2024 -125,000.00
Jun 30, 2024 -125,000.00
Mar 31, 2024 -124,000.00
Mar 31, 2024 -124,000.00